Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Regado Biosciences Company Profile (NASDAQ:RGDO)

Consensus Ratings for Regado Biosciences (NASDAQ:RGDO) (?)
Ratings Breakdown: 2 Sell Rating(s), 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $10.29 (267.35% upside)

Analysts' Ratings History for Regado Biosciences (NASDAQ:RGDO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/7/2014Needham & Company LLCDowngradeBuy -> Hold$13.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2014BMO Capital MarketsDowngradeOutperform -> Underperform$1.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2014WedbushDowngradeOutperform -> Underperform$10.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2014Jefferies GroupInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Needham & Company LLCLower Price TargetBuy$16.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Deutsche BankInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/10/2014BMO Capital MarketsReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
9/16/2013WedbushInitiated CoverageOutperform$10.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Needham & Company LLCInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Cowen and CompanyInitiated CoverageOutperform$14.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013BMO Capital MarketsInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Canaccord GenuityInitiated CoverageBuy -> Buy$14.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)